Home › Steatotic Liver Disease › Texas › Lewisville
Steatotic Liver Disease clinical trials in Lewisville, TX
3 studies for Steatotic Liver Disease are looking for participants at sites in and around Lewisville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Lewisville
- 89bio Clinical Study Site, Southlake · 11 mi away
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Lewisville
- 89bio Clinical Study Site, Southlake · 11 mi away
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RecruitingPhase 3
- GI Alliance - Southlake, Southlake · 11 mi away
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- Miami, FL16 studies
- New York City, NY16 studies
- San Diego, CA14 studies
- Houston, TX13 studies
- Austin, TX13 studies
- Richmond, VA12 studies
- Tucson, AZ10 studies
- Chandler, AZ10 studies
- Hialeah, FL9 studies
- Dallas, TX9 studies
- Orlando, FL9 studies
Other studies in Lewisville
- Ulcerative Colitis10 studies
- Crohn's Disease9 studies
- Type 2 Diabetes5 studies
- Breast Cancer5 studies
- Spinal Muscular Atrophy4 studies
- Inflammatory Bowel Disease4 studies
- Digestive Diseases4 studies
- Macular Degeneration3 studies
- Cardiovascular Disease3 studies
- Colorectal Cancer3 studies
- Geographic Atrophy3 studies
- Triple-Negative Breast Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.